Author

K. McGeer

Observed name: Kailee McGeer

Institution: University of Washington

Observed institutions: University of Maryland, Baltimore, University of Maryland Medical Center, University of Oregon, University of Washington

OpenAlex ID: A5000577487

Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist

2023 · David P. Nichols, Sarah J. Morgan, et al. · Journal of Clinical Investigation · 223

429: Effects of elexacaftor/tezacaftor/ivacaftor on the CF sputum microbiome: Preliminary analysis from the Promise study

2021 · S. Morgan, A. Vo, et al. · Journal of Cystic Fibrosis · 1

61 Azithromycin-induced genes may increase tobramycin resistance in Pseudomonas aeruginosa and contribute to azithromycin-tobramycin antagonism

2023 · G. Wang, S. Morgan, et al. · Journal of Cystic Fibrosis

564 Regional lung sampling after elexacaftor/tezacaftor/ivacaftor reveals Pseudomonas aeruginosa persistence in high- and low-damage segments

2022 · S. Durfey, S. Kapnadak, et al. · Journal of Cystic Fibrosis

P129 Attempting eradication of chronic cystic fibrosis lung infections using ivacaftor combined with intensive antibiotic treatment

2019 · S.L. Durfey, A.M. Ratjen, et al. · Journal of Cystic Fibrosis

Works count: 5

Citation count: 223

H-index: 1

I10-index: 1